SCHEMBL12464404

SCHEMBL12464404

O=Cc1ccc(-c2cc(F)cc(F)c2)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
KIF11 P52732 1/20 0.39
PTGS1 P23219 1/20 0.37
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PTGS2 P35354 1/20 0.36
RAB9A P51151 1/20 0.36
ERN1 O75460 2/20 0.36
DRD1 P21728 2/20 0.34
POLB P06746 1/20 0.34
HPGD P15428 1/20 0.34
TSHR P16473 1/20 0.33
DRD2 P14416 1/20 0.33
DRD4 P21917 1/20 0.33
DRD5 P21918 1/20 0.33
DRD3 P35462 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6142514 0.85 PTGS1 (0.51) ALDH1A1SMN1; SMN2PDE3BPDE3AKIF11
SCHEMBL6852399 0.83 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2KIF11KDM4EPTGS2
SCHEMBL15341612 0.81 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2KIF11PTGS1KDM4E
SCHEMBL257774 0.81 MEN1 (0.46) ALDH1A1SMN1; SMN2PTGS1KDM4EMEN1
SCHEMBL14879562 0.80 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2KIF11PTGS1KDM4E
SCHEMBL14879527 0.78 HSD17B10 (0.52) ALDH1A1SMN1; SMN2KIF11PTGS1KDM4E
SCHEMBL4892898 0.78 ALDH5A1 (0.52) ALDH1A1SMN1; SMN2PDE3BPDE3AKIF11
SCHEMBL416643 0.77 PTGS1 (0.51) ALDH1A1KIF11PTGS1KDM4EMEN1
SCHEMBL31120808 0.77 PTGS1 (0.51) ALDH1A1KIF11PTGS1KDM4EMEN1
SCHEMBL6854203 0.76 ALDH1A1 (0.49) ALDH1A1SMN1; SMN2KIF11KDM4EPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8337718-B2 Liquid crystal compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2012-12-25 US disclosed
US-20110180756-A1 LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE CHISSO CORPORATION (JP) 2011-07-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110180756-A1 LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE LASP1, VCL, NLK ALDH1A1 3939/4885SMN1; SMN2 2261/4885PDE3B 2330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.